StockData
Cardio Diagnostics Holdings, Inc. logo

Cardio Diagnostics Holdings, Inc. (CDIOW) stock

CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $4.94MP/E –Yield –

Cardio Diagnostics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cardio Diagnostics's enterprise value was $4.85M on Oct 19, 2026, against -$2.66M a year earlier. Over the last 5 years it ranged from -$8.10M to $33.09M, with a median of $6.48M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$4.85M+1.4%
2025Dec 31, 2025$4.79M-81.5%
2024Dec 31, 2024$25.84M-11.0%
2023Dec 29, 2023$29.04M–
2022Dec 30, 2022-$7.94M–

More Cardio Diagnostics figures